Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Gavin L Noble , Gary V Heller Added: 3 years ago
Coronary artery disease (CAD) is the leading cause of death in the US in both men and women, and in all ethnic groups that have been evaluated. The American College of Cardiology estimated the 1998 annual costs (direct and indirect) of CAD in the US to be US$368.4 billion, compared with cumulative cancer costs of US$189 billion. The national focus on cardiovascular research, diagnosis and… View more
Billy A. Caceres, PhD, RN, FAHA, FAAN is an Assistant Professor at the School of Nursing and the Center for Sexual and Gender Minority Health Research at Columbia University. Caceres is also an affiliated investigator of the Center for Research on People of Color and the Precision in Symptom Self-Management (PriSSM) Center at Columbia University School of Nursing. Caceres completed his PhD at the… View more
Author(s): Hou Tee Lu , Rusli Bin Nordin , Aizai Azan Bin Abdul Rahim Added: 3 years ago
Heart failure (HF) is a global public health problem, affecting an estimated 26 million people worldwide and resulting in more than 1 million hospitalizations annually in the US and Europe.1 This HF pandemic is also evident in Asia and other parts of the world.2–4 Although the outcomes for HF patients have improved with the discovery of multiple evidence-based drug and device therapies,… View more
Author(s): William L Baker , William B White Added: 3 years ago
Despite advances in diagnostic and treatment modalities, hypertension remains a prevalent medical condition, affecting over 26 % of the adult population, a number expected to rise to nearly 30 % by the year 2025.1 It is a major risk factor for cardiovascular disease morbidity and mortality, including stroke, heart failure, and renal disease.2,3 Numerous investigations have demonstrated the… View more
Author(s): Joseph A Hill , Mirvat Alasnag Added: 1 year ago
Stay updated with the latest data in cardiovascular science with the help of recognised experts and new voices offering practical summaries, in-depth discussions and critical reviews. With their fingers on the pulse of cardiovascular innovation, Prof Van Mieghem and Dr Daemen offer their succinct and insightful take on the most expected trials of AHA 22 in their regular review series View… View more
Author(s): Marc Sirol Added: 3 years ago
Atherosclerosis and its thrombotic complications are the first cause of mortality and morbidity in industrialized countries. Furthermore, despite pharmacological intervention and lifestyle changes, cardiovascular disease (CVD) continues to be the principal cause of death in the US.1 Despite great advances in the understanding of the initiation and progression of atherosclerosis and its risk… View more
Author(s): Marc Sirol Added: 3 years ago
Atherosclerosis and its thrombotic complications are the first cause of mortality and morbidity in industrialized countries. Furthermore, despite pharmacological intervention and lifestyle changes, cardiovascular disease (CVD) continues to be the principal cause of death in the US. Despite great advances in the understanding of the initiation and progression of atherosclerosis and its risk… View more
Author(s): Keith C Ferdinand , Verna L Welch Added: 3 years ago
Hypertension is a major contributor to the global disease burden and is one of the leading preventable causes of premature death worldwide.1 In the US, a disproportionate burden of hypertension and its associated complications—including coronary heart disease, heart failure, stroke, and end-stage renal disease and cardiovascular disease mortality—affect African-Americans (also referred to as US… View more
Author(s): Gavin L Noble , Gary V Heller Added: 3 years ago
Introduction Coronary artery disease (CAD) is the leading cause of death in the US in both men and women, and in all ethnic groups that have been evaluated.1 The American College of Cardiology estimated the 1998 annual costs (direct and indirect) of CAD in the US to be US$368.4 billion, compared with cumulative cancer costs of US$189 billion.2 The scope of this problem is expanding as the… View more